Eyman Partners
  • About Us
    • Our Mission
    • Our Vision
    • Our Story
    • Our Team
      • About Barbara
      • About Sarah
      • About Eva
      • About Sandra
      • About Morgan
      • About Lauren
  • Our Practice
    • Our Practice
    • Our Clients
    • Our Services
  • Resources
    • Medicaid Managed Care
    • 340B Drug Discount Program
    • Medicaid DSH
    • COVID-19 Resources
  • News and Updates
  • Contact
  • Privacy Policy
Select Page

CMS Releases Final Outpatient Prospective Payment System and Physician Fee Schedule Rules

Nov 19, 2021 | Medicare, News and Updates, Rulemaking

The Centers for Medicare & Medicaid Services (CMS) has finalized its outpatient prospective payment system (OPPS) and physician fee schedule rules for calendar year 2022. In the final OPPS rule, as proposed, CMS continued controversial reimbursement cuts of 30%...

CMS Revises Co-Location Guidance Adding Flexibilities for Hospitals

Nov 12, 2021 | Medicare, News and Updates

The Centers for Medicare & Medicaid Services (CMS) has released long-awaited guidance increasing flexibility for hospitals to enter into co-location arrangements. Historically, CMS disapproved of co-location arrangements, contending that they rendered hospitals...

CMMI Releases New Strategic Objectives Focused On Health Equity

Oct 20, 2021 | Medicaid, News and Updates

The Center for Medicare and Medicaid Innovation (or “Innovation Center”) has released a white paper outlining the Center’s strategic objectives for its second decade, with the goal of achieving equitable outcomes through high-quality, affordable, person-centered care....

CMS Issues Interim Final Rule on Surprise Billing Dispute Resolution Process

Sep 30, 2021 | Legislation, News and Updates, Rulemaking

The Centers for Medicare & Medicaid Services (CMS) has released an interim final rule (IFR) establishing the independent dispute resolution (IDR) process for surprise billing disputes and a similar process for uninsured/self-pay patients, as required by the No...

HRSA Notifies Six Drug Manufacturers of Referral to OIG for Possible Penalties

Sep 22, 2021 | 340B, Litigation, News and Updates

The Health Resources and Services Administration (HRSA) has taken additional steps to require 340B drug discounts when drugs are dispensed through contract pharmacies. On September 22, HRSA followed up on earlier letters to six manufacturers refusing contract pharmacy...
« Older Entries
Next Entries »
Categories
  • 340B
  • ACA
  • Analysis
  • COVID-19
  • Directed Payments
  • DSH
  • Executive Action
  • Fraud and Abuse
  • GME
  • Guide
  • Legislation
  • Litigation
  • Medicaid
  • Medicaid DSH
  • Medicaid Managed Care
  • Medicaid Managed Page
  • Medicare
  • News and Updates
  • Resources
  • Rulemaking
  • Uncategorized
  • Waivers
Eyeman Partners logo

Attorney advertising. Prior results do not guarantee a similar outcome.

300 New Jersey Avenue NW, Suite 300
Washington, DC 20001

For Inquiries Please Contact:
Tim Kuhn, Director of Operations

(202) 567-6201

Tkuhn@eymanlaw.com

©2026 © 2025 Eyman Partners | All Rights Reserved | Website by my content co. | Privacy Policy. Web Design by My Content Company